ALEMBIC
Back to Cashflow Statement
|
ALEMBIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-48 Cr | ₹-46 Cr | ₹-5.82 Cr | ₹-15 Cr | ₹-6.41 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-48 Cr |
Mar2023 | ₹-46 Cr |
Mar2022 | ₹-5.82 Cr |
Mar2021 | ₹-15 Cr |
Mar2020 | ₹-6.41 Cr |
How is Cash Flow from Financing Activities of ALEMBIC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-48 Cr | Negative | |
Mar2023 | ₹-46 Cr | Negative | |
Mar2022 | ₹-5.82 Cr | Negative | |
Mar2021 | ₹-15 Cr | Negative | |
Mar2020 | ₹-6.41 Cr | - |
Compare Cash Flow from Financing Activities of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹2,460.7 Cr | 5.9% | -17.8% | 1.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,569.0 Cr | 2.8% | -7.5% | 2.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹146,318.0 Cr | -0.2% | -9.9% | 60.4% | Stock Analytics | |
CIPLA | ₹118,110.0 Cr | 4.4% | -0.6% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,926.0 Cr | 4.8% | -2.9% | 15.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,471.5 Cr | NA | -9.4% | -10.2% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | 5.9% |
-17.8% |
1.7% |
SENSEX | 1.4% |
-5.3% |
0.3% |
You may also like the below Video Courses